howdy Dr.....it certainly appears to me immutep are struggling to
finalise recruits for Aipac......whether that is a lack of candidates
or failure to conform to criteria restrictions I don't know.....
Recruiting trialists is not all beer and skittles, it's not just disease
issues but making sure you have enrolees who will stick the
trials out, follow all trial procedures etc....That's one of the reasons
big pharma are increasingly looking to specialist research companies
to conduct trials on their behalf in form of collaborations, partnerships
etc....
Ann: Immutep Investor Update, page-9
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |